Company news
Beta Bionics, Inc. (NASDAQ:BBNX) news
Every Beta Bionics, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance
July 29, 2026
Beta Bionics First in Automated Insulin Delivery to Publish Near Real-Time Real-World Data on a Public Website
June 2, 2026
Beta Bionics Updates Commercialization Timeline Expectations for Mint™, its Patch Pump in Development
May 21, 2026
Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance
April 21, 2026
Beta Bionics Introduces Bionic Insights™ in Bionic Reports — Transforming How Clinicians Understand and Optimize Diabetes Care
March 31, 2026
Beta Bionics to Announce First Quarter 2026 Financial Results on April 21, 2026
March 30, 2026
Beta Bionics to Present at the TD Cowen 46th Annual Health Care Conference
February 19, 2026
Beta Bionics Announces Fourth Quarter and Full Year 2025 Financial Results and Introduces Annual Guidance for Full Year 2026
February 17, 2026
Beta Bionics to Announce Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026
January 15, 2026
Beta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key Metrics
January 8, 2026
Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026
December 8, 2025
Beta Bionics Announces Participation at Upcoming Investor Conferences
November 3, 2025
Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance
October 28, 2025
Beta Bionics to Announce Third Quarter 2025 Financial Results on October 28, 2025
October 9, 2025
InspireMD Announces the Appointment of Dan Dearen to its Board of Directors
September 17, 2025
Beta Bionics Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Guidance
July 29, 2025
Beta Bionics to Announce Second Quarter 2025 Financial Results on July 29, 2025
July 2, 2025
Abvance Therapeutics Secures Strategic Seed Financing & Leadership Expansion at ADA Scientific Sessions
June 24, 2025
Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott’s Future Dual Glucose-Ketone Sensor
June 19, 2025
Beta Bionics Reports First Quarter 2025 Financial Results and Raises Annual Guidance for Full Year 2025
May 6, 2025
Beta Bionics to Present at the Bank of America Securities Health Care Conference
May 1, 2025
Beta Bionics to Announce First Quarter 2025 Financial Results on May 6, 2025
April 16, 2025
Beta Bionics to Host Investor Event on June 22, 2025
April 9, 2025
Beta Bionics Announces Board Appointment of Gerard Michel
March 27, 2025
Beta Bionics Announces Fourth Quarter and Full Year 2024 Financial Results and Introduces Annual Guidance for Full Year 2025
March 25, 2025
Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025
February 27, 2025
Beta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional...
January 31, 2025